Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01954602
Other study ID # CE 13028 TNT study
Secondary ID
Status Completed
Phase N/A
First received August 5, 2013
Last updated March 24, 2017
Start date July 2013
Est. completion date April 2015

Study information

Verified date March 2017
Source Azienda Usl di Bologna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The specific goal of this study is to compare the deep biliary cannulation rate and complication rates associated with use of touch and no touch guide-wire biliary cannulation techniques.


Description:

The most common technique used to achieve primary deep biliary cannulation is the standard contrast-assisted method, in which a catheter or sphincterotome is introduced into the papilla in the direction of the bile duct and a contrast medium injected to confirm that the duct has been cannulated.

The biliary guidewire cannulation technique consists of the introduction of a guide-wire into the bile duct instead of contrast injection as the first maneuver.

The benefit of this technique, compared with classic contrast cannulation, has been demonstrated in several studies which show similar results and have been analyzed in a recent meta-analysis, including 5 studies and 1762 patients, and demonstrating that the use of the guide-wire technique significantly improved the primary cannulation rate from 74.9% to 85.3%. More importantly, significantly reduced the incidence of PEP from 8.6% to 1.6%.

There are several variations of this technique; the tip of the sphincterotome is inserted initially a few millimeters through the papillary orifice and then introduce the guide-wire to the target ("touch technique"). Another variation is direct cannulation with the guide-wire hovering a few millimeters through the catheter or sphincterotome ("no touch technique").

To date, there are no randomized controlled trials comparing the two above described way to access to biliary duct regarding efficacy and rate of complications.


Recruitment information / eligibility

Status Completed
Enrollment 206
Est. completion date April 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 18 or older

- Clinical symptoms, laboratory findings and radiological evidences of biliary disease

- Willing and able to comply with the study procedures and provide written informed consent to participate in the study

Exclusion Criteria:

- Age <18 yars

- Patients with previous sphincterotomy

- Patients with previous papillary endoscopic balloon dilation

- Presence of a previously placed plastic or metal biliary stent

- Presence of any esophageal or gastro/duodenal stent

- Pancreatic or ampullary cancer, proven by imaging and/or cytology and/or histology, are excluded as PEP is very uncommon in these subgroups and tumour-related anatomical variation may alter cannulation technique (consider substratify results for this subgroup, but exclude if duodenal stenosis precludes an attempt on the papilla)

- Patients with surgically altered anatomy (Bilroth II gastrectomy and Roux en Y anastomosis) are excluded as cannulation technique is fundamentally different from that in normal anatomy

- Presence of a diverticular papilla

- Presence of a duodenal stenosis

- Presence of a pancreas divisum

- Patients with contraindication to endoscopic procedures

- Hemodinynamic instability, any acute illness or exacerbation of chronic illness, acute infections.

- Platelet count less than 50,000/mm3 and INR no greater than 1.5 times upper limit of normal

- Inability or refusal to give informed consent.

- Refusal to provide consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Guide-wire cannulation
Direct guide-wire hovering a few millimeters through the catheter or sphincterotome
Sphincterotome assisted guide-wire cannulation
Sphincterotome is inserted initially a few millimeters through the papillary orifice

Locations

Country Name City State
Italy Azienda Unità Sanitaria Locale Bologna

Sponsors (3)

Lead Sponsor Collaborator
Azienda Usl di Bologna Catania Hospital Gastroenterology, Niguarda Hospital

Country where clinical trial is conducted

Italy, 

References & Publications (5)

Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991 May-Jun;37(3):383-93. Review. — View Citation

Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996 Sep 26;335(13):909-18. — View Citation

Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998 Jul;48(1):1-10. — View Citation

Rabenstein T, Schneider HT, Nicklas M, Ruppert T, Katalinic A, Hahn EG, Ell C. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc. 1999 Nov;50(5):628-36. — View Citation

Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology. 1991 Oct;101(4):1068-75. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cannulation success rate No more than 5 minutes of biliary cannulation or 5 unintended pancreatic duct cannulation with the guidewire, with both techniques
Secondary Incidences of PEP from the intervention until two days
See also
  Status Clinical Trial Phase
Completed NCT02971579 - A Register on the Quality of ERCP and Training of Endoscopists in Italy
Recruiting NCT02310230 - An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy N/A
Not yet recruiting NCT01900938 - Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP N/A
Completed NCT00370344 - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Phase 2/Phase 3
Suspended NCT04559867 - Fistulotomy as the Primary Cannulation Technique for All Patients Undergoing ERCP: A Randomized, Controlled Trial N/A
Enrolling by invitation NCT04572711 - Prospective Evaluation of Biliary Tissue Sampling With ERCP
Recruiting NCT01715220 - Treatment of Suspected Cholelithiasis With Nitroglycerin Phase 2
Recruiting NCT05249400 - Effect of Off-site Assistance on Success Rate of Selective Cannulation During hands-on ERCP Training N/A
Completed NCT02287194 - SpyGlass Direct Visualization System Clinical Registry in China
Active, not recruiting NCT03190343 - Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases
Withdrawn NCT00672698 - Evaluation of Surgical Risk in Elderly Patients Submitted to Elective Surgery N/A
Completed NCT00751998 - Spy II Clinical Registry
Completed NCT04604652 - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis Phase 2
Completed NCT02353286 - Endoscopic Treatment of Benign Biliary Strictures and Cystic Duct Leakages With a Novel Biodegradable Biliary Stent N/A
Recruiting NCT03074708 - Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery N/A
Not yet recruiting NCT06276153 - Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
Withdrawn NCT03678480 - A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) Phase 2
Completed NCT04115696 - Biodegradable Stent Implantation in Biliary Benign Strictures.
Recruiting NCT04391426 - Analysis of Biliary Microbiota in Hepatobiliopancreatic Diseases Compared to Healthy People [MICROBILIO]
Completed NCT01350037 - Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4